Privately owned personalized medicine company
Enterome has raised €78M across 4 funding rounds from 5 investors, most recently a round in Jun 2025. Based in Paris, France; founded 2007; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-06-12 | Other | €16M | existing specialist investors,The Institute for Follicular Lymphoma Innovation (IFLI) ,The Leukemia & Lymphoma Society Therapy Acceleration Program® (LLS TAP) | View deal → |
| 2020-06-25 | Series D+ | €46M | — | View deal → |
| 2014-05-01 | Other | €10M | Omnes Venture Capital | View deal → |
| 2012-03-01 | Series A | €5.0M | Seventure Partners | View deal → |
